The proposed research focuses on both reversible and irreversible mitochondrial inner membrane functional changes which occur in ischemic and autolyzing myocardium.
The first aim of our planned work is the further characterization of the reversible inhibition of the mitochondrial ATPase which occurs in ischemic myocardium apparently as a direct result of lowered cell pH in the absence of electron flow.
The second aim i s the determination of the mechanism of the reactivation of the inhibited ATPase upon reperfusion in situ or upon state 4 re-energization in vitro.
The third aim i s the determination of the time course of the loss of mitochondrial competence, i.e., their ability to generate a transmembrane electrochemical gradient. The last aim is the determination of the relative and combined contributions of tissue acidosis and of tissue ATP depletion to the onset and progression of irreversible mitochondrial functional impairment which occurs during myocardial autolysis. Our data thus far suggest the following hypothesis, that the underlying mechanism of the ATPase inhibition is the reversible association of the ATPase inhibitor protein (AIP) of Pullman and Monroy which acts to block a dissipative ATP hydrolysis by the undriven ATP sysnthetase (in ischemia) but does not prevent renewed ATP synthesis upon re-energization (reflow). Other data suggest that beyond 20 min of myocardial autolysis, an increasing, irreversible impairment of electron flow at the NADH-CoQ reductase site may prevent total ATPase reactivation upon reflow or attempted re-energization. The ATPase inhibition work will be approached using submitochondrial particle (SMP) preparations of the following types: (1) control, (2) autolyzed, (3) energized, and (4) AIP-depleted. Immunoradiometric detection of the AIP on SMP will be used in conjunction with ATPase activity and kinetics measurements to verify the relationship between ATPase activity regulation and the presence or affinity of the AIP in the four types of SMP preparations to be used: The ability of ischemically damaged mitochondria to generate a membrane potential will be determined using their ability to reactivate their inhibited ATPase upon re-energization, as well as by an independent spectrophotometric method utilizing the dye, safronin O. The characterization of the reversible, regulatory inhibition of the mitochondrial ATPase is potentially of central importance to our understanding of the ability of heart muscle to react to oxygen depletion and acidosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL030926-02
Application #
3341939
Study Section
Physical Biochemistry Study Section (PB)
Project Start
1984-09-01
Project End
1987-08-31
Budget Start
1985-09-01
Budget End
1986-08-31
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Rouslin, W; Broge, C W (1996) Isoform-independent heart rate-related variation in cardiac myofibrillar Ca(2+)-activated Mg(2+)-ATPase activity. Am J Physiol 270:C1271-6
Rouslin, W; Broge, C W (1996) Novel difference in IF1 reactivity to Zn2+ in rabbit versus rat cardiomyocytes, mitochondria, and submitochondrial particles. Biochem Biophys Res Commun 227:8-14
Rouslin, W; Broge, C W (1996) IF1 function in situ in uncoupler-challenged ischemic rabbit, rat, and pigeon hearts. J Biol Chem 271:23638-41
Rouslin, W; Frank, G D; Broge, C W (1995) Content and binding characteristics of the mitochondrial ATPase inhibitor, IF1, in the tissues of several slow and fast heart-rate homeothermic species and in two poikilotherms. J Bioenerg Biomembr 27:117-25
Rouslin, W; Broge, C W; Guerrieri, F et al. (1995) ATPase activity, IF1 content, and proton conductivity of ESMP from control and ischemic slow and fast heart-rate hearts. J Bioenerg Biomembr 27:459-66
Rouslin, W; Broge, C W (1994) Analysis of factors affecting functional assays for estimating IF1, the mitochondrial ATPase inhibitor. Anal Biochem 222:68-75
Rouslin, W; Broge, C W (1993) Mechanisms of ATP conservation during ischemia in slow and fast heart rate hearts. Am J Physiol 264:C209-16
Rouslin, W; Broge, C W (1993) Factors affecting the species-homologous and species-heterologous binding of mitochondrial ATPase inhibitor, IF1, to the mitochondrial ATPase of slow and fast heart-rate hearts. Arch Biochem Biophys 303:443-50
Rouslin, W; Broge, C W; Chernyak, B V (1993) Effects of Zn2+ on the activity and binding of the mitochondrial ATPase inhibitor protein, IF1. J Bioenerg Biomembr 25:297-306
Rouslin, W; Broge, C W; Chernyak, B V (1992) Zn2+ allows differentiation between two kinds of IF1-ATPase interaction in intact mitochondria. Ann N Y Acad Sci 671:507-8

Showing the most recent 10 out of 25 publications